Evaluation of neurocognitive deficits following recovery from mild COVID-19


  • Neurocognitive deficits are sustained after recovery from uncomplicated coronavirus 2019 (COVID-19) in young patients and can be identified through targeted screening.

Why this matters

    Understanding potential neurocognitive effects of COVID-19, their causes, and how to screen for them may prevent adverse outcomes.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.